"Learn more about the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, which offers nearly every aspect of outpatient cancer care across many specialties. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 833-494-2758, Monday through Friday between 8:00 AM and 6:00 PM ET."

During the past decade, Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care" #1 sponsor was "Pfizer" with 7 trials, followed by "Celgene" with 2 trials sponsored, "NexImmune Inc." with 2 trials sponsored, "Aadi Bioscience, Inc." with 1 trials sponsored and "C4 Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care" are "Multiple Myeloma" (4 trials), "Solid Tumor" (3 trials), "Neoplasms" (2 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Advanced Cancer" (1 trials). Many other conditions were trialed in "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care" are "Drug" (17 trials), "Biological" (4 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "binimetinib" (2 trials), "encorafenib" (2 trials), "5Fluorouracil" (1 trials), "Abemaciclib" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care". 1 are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care, 11 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".